07-21-2009, 09:51 PM
|
#10
|
|
Come on, cat.
Join Date: Nov 2003
Location: general vicinity of Philadelphia area
Posts: 7,013
|
Publisher consulted drug firm on journal content.
Quote:
Documents tendered to a Federal Court class action reveal staff at publishing company Elsevier, which produces The Lancet, emailed pharmaceutical giant Merck & Co about its "preferred content selection" for the Australasian Journal of Bone and Joint Medicine.
The publisher also admits the journal is a "single sponsored publication" where most of the content is chosen by Merck with some "input from Elsevier".
The plaintiff in the class action has alleged the journal was fake and it was simply a marketing exercise designed to promote Vioxx. The court has also heard Merck put the names of high-profile arthritis experts on the editorial board of the phoney journal without telling them they had done so. (Holy shit!)
Since these revelations, Elsevier has expressed embarrassment over its role and admitted it failed to meet its own "high standards for disclosure".
|
__________________
Crying won't help you, praying won't do you no good.
|
|
|
Threaded Mode